-+ 0.00%
-+ 0.00%
-+ 0.00%

Anika Therapeutics Director John B. Henneman III acquires 5,000 shares for $73,319.50

PUBT·05/04/2026 12:35:13
Listen to the news
Anika Therapeutics Director John B. Henneman III acquires 5,000 shares for $73,319.50
  • John B. Henneman III, director, bought 5,000 Anika Therapeutics common shares.
  • Purchase price USD 14.66 per share.
  • Direct holdings increased to 54,871 shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Anika Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-202704), on May 04, 2026, and is solely responsible for the information contained therein.